|Articles|May 17, 2023

Pharma USA 2023: Conversational AI

In this interview, Arun Thachi, Director, Head of IT Marketing and Sales, Boehringer Ingelheim, discusses the AI journey in pharma.

Arun Thachi, Director, Head of IT Marketing and Sales, Boehringer Ingelheim, explains conversational AI and how it can be best-used in pharma to inform and engage.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

stock.adobe.com fibrosis

Aptar and Aceso Therapeutics Enter Collaboration for Cystic Fibrosis Therapy

ByNicholas Jacobus

September 8th 2026

Parth Khanna

Why AI Trust Comes Down to One Equation: Q&A with Parth Khanna

ByMike Hollan,Parth Khanna

September 1st 2026

Parth Khanna

The Future Relationship Between AI and Field Reps

ByMike Hollan,Parth Khanna

August 31st 2026

Rafaat Rahmani

Pharma Has More Data Than Ever, This Doesn’t Mean It Has Better Intelligence

ByRafaat Rahmani

August 31st 2026

Parth Khanna

How AI is Being Implemented Alongside Compliance Concerns

ByMike Hollan,Parth Khanna

August 28th 2026

Trending on PharmExec

Advancements in Oral Treatments for IBD

Moonwalk Biosciences Closes $70 Million Series B

Your Questions Answered: The Biggest Pharma and Biotech Stories This Week

The Real Cost of Flexibility: Q&A With Sebastian Arana

IBD's Potential Missing Piece: Q&A with Christian Thienel